Skip to content

Clinical trials

Terminated Leiomyosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Status: Terminated Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20112
20151
20162
20172
20192
20201
20211
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Benjamin Izar1
Boundless Bio, Inc.1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
M.D. Anderson Cancer Center1
Medical University of Graz1
Memorial Sloan Kettering Cancer Center1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma18
Sarcoma7
Histiocytoma, Malignant Fibrous6
Liposarcoma5
Neurofibrosarcoma3
Sarcoma, Synovial3
Triple Negative Breast Neoplasms3
Chondrosarcoma2
Dermatofibrosarcoma2
Endometrial Neoplasms2

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.